Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc. New name reflects dedication to patient-inspired mission of identifying, developing and delivering life-changing rare disease therapies Company’s shares to trade under new ticker symbol TVTX on...

Retrophin to Report First Quarter 2020 Financial Results SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report first quarter 2020 financial results on Monday, May 11, 2020 after the close of the U.S....